Delivery Order SPE2DB20D2104-SPE2DB23FR03J
Award Date 11/9/22
Potential Completion Date 11/10/22
Potential Value $1.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro 10 mg/0.5 ml pen (0.5 ml). The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $12,739.21 and an ultimate completion date of October 17, 2024. The contract is a delivery order with a firm fixed-price pricing type and does not have a set-aside designation. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Mounjaro 5 mg/0.5 ml pen. The contract, valued at $3,156.00, is a firm fixed-price delivery order with a completion date of March 28, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,119.96 firm fixed-price delivery order is for the medication Mounjaro 5 mg/0.5 ml pen (0.5 ml). The contract has an ultimate completion date of June 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,447.12, is a delivery order to supply the medication Mounjaro (5 mg/0.5 ml pen) for the DLA. The contract has a ceiling value of $5,447.12 and a period of performance through February 28, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,260, is a delivery order for the medication Mounjaro 7.5 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of November 15, 2024 and is a firm fixed price contract. AmerisourceBergen Drug Corp is the prime contractor, and the contract was not designated with a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Mounjaro 5 mg/0.5 mL pen 0.5 mL. The contract has a ceiling value of $2,104.00 and a period of performance through October 18, 2024. This appears to be a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a ceiling value of $1,052. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of the drug Mounjaro 15 mg/0.5 ml pen. The contract is a firm fixed-price arrangement with an ultimate completion date of August 23, 2024. AmerisourceBergen, the prime contractor, holds several indefinite delivery contracts (IDCs) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,189.22, is for the delivery of the drug Mounjaro 7.5 mg/0.5 mL pen 0.5 mL. The contract has an ultimate completion date of April 7, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro (2.5 mg/0.5 ml pen, 0.5 ml) with a ceiling value of $1,578. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 28, 2024. This appears to be a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 15 mg/0.5 ml pens. The contract has a ceiling value of $1,315.00 and is a firm fixed price delivery order with an ultimate completion date of October 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FR03JDelivery Order
This federal contract award to AmerisourceBergen Drug Corp (AmerisourceBergen) is for the delivery of the medication Mounjaro 5 mg/0.5 ml pen, 0.5 ml. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $1,717.51 and an ultimate completion date of November 10, 2022. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.
Generated 2/27/25, 1:29 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/9/22 |